A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Clinical trial NCT00481247 · COMPLETED
Trial details
- NCT number
- NCT00481247
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-12-01
- Enrollment
- 547
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.